donor < dopa < dopaminagonists

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]

Ident.	Authors (with country if any)	Title
000089 (2013)	Erwan Bezard [France]	Experimental reappraisal of continuous dopaminergic stimulation against L‐dopa‐induced dyskinesia
000491 (2010)	Richard Delorme [France] ; Catalina Betancur [France] ; Pauline Chaste [France] ; Solen Kernéis [France] ; Astrid Stopin [France] ; Marie-Christine Mouren [France] ; Corinne Collet [France] ; Thomas Bourgeron [France] ; Marion Leboyer [France] ; Jean-Marie Launay [France]	Reduced 3‐O‐methyl‐dopa levels in OCD patients and their unaffected parents is associated with the low activity M158 COMT allele
000642 (2009)	Kiyoka Kinugawa [France] ; Emmanuel Itti [France] ; Jean-Francois Lepeintre [France] ; Ivan Mari [France] ; Virginie Czernecki [France] ; Francoise Heran [France] ; Stephane Clemenceau [France] ; Marie Vidailhet [France] ; Emmanuel Roze [France]	Subacute dopa‐responsive parkinsonism after successful surgical treatment of aqueductal stenosis
000A14 (2006)	Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni]	Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa
000A30 (2006)	Paolo Gubellini [France] ; Alexandre Eusebio [France] ; Abid Oueslati [France] ; Christophe Melon [France] ; Lydia Kerkerian-Le Goff [France] ; Pascal Salin [France]	Chronic high‐frequency stimulation of the subthalamic nucleus and L‐DOPA treatment in experimental parkinsonism: effects on motor behaviour and striatal glutamate transmission
000C33 (2004)	S. Robelet [France] ; C. Melon [France] ; B. Guillet [France] ; P. Salin [France] ; L. Kerkerian-Le Goff [France]	Chronic l‐DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease
000D34 (2002)	Lance A. Smith [Royaume-Uni] ; Banu C. Tel [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Rogelio Braceras [Royaume-Uni] ; Céline Bonhomme [France] ; Claire Chezaubernard [France] ; Susanna Del Signore [France] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni]	Repeated administration of piribedil induces less dyskinesia than L‐dopa in MPTP‐treated common marmosets: A behavioural and biochemical investigation
001060 (2000)	Imad Ghorayeb [France] ; Pierre O. Fernagut [France] ; Incarnation Aubert [France] ; Erwan Bezard [France] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] ; François Tison [France]	Toward a primate model of l‐dopa‐unresponsive parkinsonism mimicking striatonigral degeneration
001301 (1999)	Christine Dentresangle [France] ; Laurent Veyre [France] ; Didier Le Bars [France] ; Christian Pierre [France] ; Frank Lavenne [France] ; Pierre Pollak [France] ; Jeanine Guerin [France] ; Jean-Claude Froment [France] ; Emmanuel Brousolle [France]	Striatal D2 dopamine receptor status in Parkinson's disease: An [18F]dopa and [11C]Raclopride PET study
001374 (1999)	C. Cleren [France] ; C. Vilpoux [France] ; N. Dourmap [France] ; J.-J Bonnet [France] ; J. Costentin [France]	Acute interactions between l-DOPA and the neurotoxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine in mice
001503 (1998)	Th Boraud [France] ; E. Bezard [France] ; D. Guehl [France] ; B. Bioulac [France] ; Ch Gross [France]	Effects of l-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey
001739 (1996)	Hugues Duffau [France] ; Nathalie Tzourio [France] ; Dominique Caparros-Lefebvre [France] ; Fabrice Parker [France] ; Bernard Mazoyer [France]	Tremor and voluntary repetitive movement in Parkinson's disease: comparison before and after l -dopa with positron emission tomography
001756 (1996)	X. Picard [France] ; A. De Saint-Martin [France] ; E. Salmon [Belgique] ; E. Hirsch [France] ; C. Marescaux [France]	Postencephalitic stereotyped involuntary movements responsive to L‐Dopa
001790 (1996)	Cecilia Lundberg [Suède] ; Philippe Horellou [France] ; Jacques Mallet [France] ; Anders Björklund [Suède]	Generation of DOPA-Producing Astrocytes by Retroviral Transduction of the Human Tyrosine Hydroxylase Gene: In Vitro Characterization and in Vivo Effects in the Rat Parkinson Model
001791 (1996)	Cecilia Lundberg [Suède] ; Philippe Horellou [France] ; Jacques Mallet [France] ; Anders Björklund [Suède]	Generation of DOPA-Producing Astrocytes by Retroviral Transduction of the Human Tyrosine Hydroxylase Gene: In Vitro Characterization and in Vivo Effects in the Rat Parkinson Model
001792 (1996)	Cecilia Lundberg [Suède] ; Philippe Horellou [France] ; Jacques Mallet [France] ; Anders Björklund [Suède]	Generation of DOPA-Producing Astrocytes by Retroviral Transduction of the Human Tyrosine Hydroxylase Gene: In Vitro Characterization and in Vivo Effects in the Rat Parkinson Model
001816 (1996)	Abdelhamid Benazzouz [France] ; Thomas Boraud [France] ; Jean Féger [France] ; Pierre Burbaud [France] ; Bernard Bioulac [France] ; Christian Gross [France]	Alleviation of experimental hemiparkinsonism by high‐frequency stimulation of the subthalamic nucleus in primates: A comparison with L‐dopa treatment
001946 (1995)	R. Levy [France] ; M. T. Herrero [France, Espagne] ; M. Ruberg [France] ; J. Villares [France] ; B. Faucheux [France] ; J. Guridi [Espagne] ; J. Guillen [Espagne] ; M. R. Luquin [Espagne] ; F. Javoy-Agid [France] ; J. A. Obeso [Espagne] ; Yves Agid [France] ; E. C. Hirsch [France]	Effects of Nigrostriatal Denervation and L‐Dopa Therapy on the GABAergic Neurons of the Striatum in MPTP‐treated Monkeys and Parkinson's Disease: An In Situ Hybridization Study of GAD67 mRNA
001B70 (1993)	Bernard Aranda [France] ; Philippe Cramer [France]	Effects of apomorphine and L‐dopa on the parkinsonian bladder
001D59 (1991)	F. Tison [France] ; N. Mons [France] ; M. Geffard [France] ; P. Henry [France]	The metabolism of exogenous L-Dopa in the brain: An immunohistochemical study of its conversion to dopamine in non-catecholaminergic cells of the rat brain
001E01 (1991)	Anne-Marie Ferrandez [France] ; Olivier Blin [France]	A comparison between the effect of intentional modulations and the action of l-Dopa on gait in Parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "dopa" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "dopa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    dopa
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024